Abstract:The applicant Detia Freyberg GmbH submitted to the competent national authority in Germany two requests to evaluate the confirmatory data that were identified for tree nuts, oilseeds, cereals and commodities of animal origin in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available and two requests in accordance with Article 6 of Regulation (EC) No 396/2005 to increase the existing MRL for the active substance aluminium phosphide in peanuts, barley, oat, rye, rice and wheat, roots of herbal infusions, cocoa beans and seed spices and for the active substance magnesium phosphide in oilseeds (except peanuts) and pistachios. The four applications were combined by EFSA under the current assessment. To address the data gaps, validation data for the method of analysis for enforcement of phosphide in high-oil content commodities and new residue trials were submitted. The data gaps on additional residue trials supporting authorisations on oilseeds and cereal grains, on clarifications regarding the discrepancies observed in the residue trial results for pistachios, and on data confirming the negligible occurrence of phosphane and its oxidation products in livestock products were considered addressed. The data gap on independent laboratory validation (ILV) and a confirmatory method for monitoring of phosphide in high-oil content commodities was considered not fully addressed. The information provided justified a lowering of the current tentative MRLs for the whole group of cereals (except rice and 'others'), an increase of the current tentative MRLs for pistachios, the whole group of oilseeds, rice and 'other' cereals, herbal infusions from roots, cocoa beans and seed spices, and a revision of the risk assessment performed for phosphane and its phosphide salts. Based on the risk assessment results, EFSA concluded that the short-term and long-term intake of residues resulting from the use of AlP and Mg3P2 according to the reported agricultural practices is unlikely to present a risk to consumer health. Further risk management considerations are required.

Updated peer review of the pesticide risk assessment of the active substance pydiflumetofen

Peer review of the pesticide risk assessment of the active substance bensulfuron-methyl

Peer review of the pesticide risk assessment of the active substance chlorothalonil

Peer review of the pesticide risk assessment of the active substance beta‐cyfluthrin

Updated peer review of the pesticide risk assessment of the active substance asulam (variant evaluated asulam‐sodium)

Peer review of the pesticide risk assessment of the active substance Ampelomyces quisqualis strain AQ10

Peer review of the pesticide risk assessment of the active substance Bacillus velezensis RTI301

Peer review of the pesticide risk assessment of the active substance Bacillus subtilis strain RTI477

Peer review of the pesticide risk assessment of the active substance milbemectin

Peer review of the pesticide risk assessment of the active substance glyphosate

Peer review of the pesticide risk assessment of the active substance aqueous extract from the germinated seeds of sweet Lupinus albus

Peer review of the pesticide risk assessment of the active substance Straight Chain Lepidopteran Pheromones (SCLPs)

Peer review of the pesticide risk assessment of the active substance captan

Evaluation of confirmatory data following the Article 12 MRL review for fluroxypyr

Modification of the existing maximum residue levels for chlorpyrifos‐methyl in kaki/Japanese persimmon and granate apple/pomegranate

Evaluation of confirmatory data following the Article 12 MRL review for myclobutanil

Review of the existing maximum residue levels for difenoconazole according to Article 12 of Regulation (EC) No 396/2005

Evaluation of confirmatory data following the Article 12 MRL review for quizalofop-P-ethyl, quizalofop-P-tefuryl and propaquizafop and modification of the existing maximum residue levels for quizalofop-P-tefuryl

Review of the existing maximum residue levels for Beta‐cyfluthrin and Cyfluthrin according to Article 12 of Regulation (EC) No 396/2005

Evaluation of confirmatory data following the Article 12 MRL review for fenbuconazole

Evaluation of confirmatory data following the Article 12 MRL review and modification of the existing maximum residue levels for aluminium phosphide and magnesium phosphide